drugset / Trial / NCT01509391

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

NCT01509391

Completed 14 enrolled Medical University of Graz
NaSingle-groupOpen-labelTreatment

Summary

In this study the investigators examine the safety and efficacy of Keyhole-limpet-hemocyanin in patients with chronic hepatitis c infection and liver cirrhosis. The investigators hypothesize that administration of keyhole-limpet-hemocyanin reduces the viral load in patients infected with hepatitis c.

Timeline

Start
2012-01
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject keyhole limpet hemocyanin Vaccine Subcutaneous